Adverse Outcomes After Percutaneous Coronary Intervention More Prevalent in Systemic Sclerosis
Patients with systemic sclerosis and systemic lupus erythematosus were found to be at increased odds of adverse clinical outcomes and bleeding, respectively, after percutaneous coronary intervention.